# Intradermal Trivalent Influenza Vaccine With Imiquimod

> **NCT01508884** · NA · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 93 (actual)

## Conditions studied

- Chronic Illness

## Interventions

- **BIOLOGICAL:** influenza vaccine
- **DRUG:** Imiquimod
- **BIOLOGICAL:** influenza vaccine
- **DRUG:** Aqueous cream
- **BIOLOGICAL:** influenza vaccine
- **DRUG:** Aqueous cream

## Key facts

- **NCT ID:** NCT01508884
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2013-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01508884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01508884, "Intradermal Trivalent Influenza Vaccine With Imiquimod". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01508884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*